Current role
Biotechnology · Healthcare
Chairman, Board Member
2023-02-23–present
Richard Heyman, Ph.D.
Chairman
Enliven Therapeutics, Inc. (ELVN)Board Member
Enliven Therapeutics, Inc. (ELVN)Equibles does not estimate personal net worth.
Get an email with a short summary when Enliven Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELVN alertsAbout Richard Heyman, Ph.D.
Richard Heyman, Ph.D. is recorded as Chairman and Board Member at Enliven Therapeutics, Inc. (ELVN) since February 23, 2023. Enliven Therapeutics, Inc. reported in an 8-K filed March 1, 2023 that Richard Heyman, Ph.D. was appointed Executive Chairman of the Board, effective February 23, 2023. Enliven Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Enliven Therapeutics, Inc. includes Richard Fair (CEO and Board Member), Rick Fair (CEO and Board Member), Sam Kintz, M.B.A. (CEO and Board Member) and 7 others.
“Dr. Heyman was appointed as the Executive Chairman of the Board.”
Affiliation history
-
Current
2023-02-23–present
-
Current
2023-02-23–present
Company network
Leadership on record at Enliven Therapeutics, Inc.
- Richard Fair CEO, Board Member
- Rick Fair CEO, Board Member
- Sam Kintz, M.B.A. CEO, Board Member
- Samuel Kintz CEO
- Ben Hohl CFO
- Benjamin Hohl CFO
- Anish Patel COO
- Andrew Phillips, Ph.D. Board Member
- Continuing Directors Board Member
- Jake Bauer Board Member